LIVN
LivaNova PLC Healthcare - Medical Devices Investor Relations →
LivaNova PLC (LIVN) closed at $66.56 as of 2026-02-02, trading 26.8% above its 200-week moving average of $52.50. The stock moved further from the line this week, up from 24.9% last week. With a 14-week RSI of 74, LIVN is in overbought territory.
Over the past 489 weeks of data, LIVN has crossed below its 200-week moving average 12 times. On average, these episodes lasted 25 weeks. The average one-year return after crossing below was -14.5%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $3.6 billion, LIVN is a mid-cap stock. The company generates a free cash flow yield of 24.5%, which is notably high. Return on equity stands at -17.6%. The stock trades at 3.1x book value.
Over the past 9.5 years, a hypothetical investment of $100 in LIVN would have grown to $111, compared to $373 for the S&P 500. LIVN has returned 1.1% annualized vs 14.9% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: LIVN vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After LIVN Crosses Below the Line?
Across 12 historical episodes, buying LIVN when it crossed below its 200-week moving average produced an average return of -14.8% after 12 months (median -28.0%), compared to +4.2% for the S&P 500 over the same periods. 18% of those episodes were profitable after one year. After 24 months, the average return was +1.5% vs +26.1% for the index.
Each line shows $100 invested at the moment LIVN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
LIVN has crossed below its 200-week MA 12 times with an average 1-year return of +-14.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Oct 2016 | May 2017 | 26 | 24.9% | +82.5% | +48.6% |
| Apr 2019 | Jul 2019 | 16 | 7.9% | -39.3% | -4.5% |
| Sep 2019 | Oct 2019 | 2 | 3.5% | -34.7% | -6.7% |
| Oct 2019 | Nov 2019 | 2 | 5.1% | -28.0% | -4.8% |
| Dec 2019 | Feb 2021 | 60 | 51.5% | -8.7% | -8.2% |
| Mar 2021 | Apr 2021 | 2 | 4.2% | +3.0% | -12.4% |
| Jul 2021 | Jul 2021 | 1 | 0.5% | -21.0% | -14.3% |
| Aug 2021 | Aug 2021 | 1 | 1.8% | -15.9% | -13.5% |
| Oct 2021 | Nov 2021 | 1 | 2.1% | -38.1% | -13.2% |
| Jan 2022 | Mar 2022 | 7 | 9.0% | -22.3% | -6.5% |
| Apr 2022 | Aug 2025 | 173 | 42.2% | -37.5% | -13.2% |
| Sep 2025 | Nov 2025 | 7 | 6.3% | N/A | +24.6% |
| Average | 25 | — | +-14.5% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02